Search results for: Diagnostics and Imaging
Filter search results
Taking STRIDES: The value of diagnostics against AMR
10 June 2025
…better surveillance and treatment outcomes. Yet, despite this, diagnostics remain underutilised in both policy and practice. One major barrier to the uptake and effective use of AMR diagnostics is the…
A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance
19 May 2023
…antibiotics that could inform longer-term financing and reimbursement arrangements and guide prescribing behaviours. Key takeaways Antimicrobial resistance (AMR) threatens our ability to treat common infections, and antibiotic stewardship is critical…
The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics
5 July 2016
…of risk assessment, diagnosis, prognosis, monitoring, and guiding therapeutic decisions. This broad definition encompasses companion diagnostics and next-generation sequencing (NGS) as subsets of complementary diagnostics. FDA has recently begun to…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 April 2012
…pricing and reimbursement systems for diagnostics, however, are not efficient and provide poor incentives… Diagnostics not only facilitate health gain and cost savings, but also provide information to inform patients’…
Personalised Medicine and the Value of Molecular Diagnostics: Case Studies
18 December 2013
…authors point out, this sample of cases illustrates the diversity of approaches in developing molecular diagnostics and the range of challenges posed both by the science and in acceptance and…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 May 2012
…The authors note that diagnostics not only facilitate health gain and cost savings, but also provide information to inform patients’ decisions on interventions and to clarify how their behaviour may…
Personalised Medicine: Economic Incentives for Evidence Generation
28 October 2013
…challenges. Encouraging more rapid progress in the development and availability of drugs and diagnostics that are essential to personalised medicine requires appropriate sets of economic incentives. Towse and Garrison identify…
OHE Involved in Developing New AMS Report on Stratified Medicines
15 July 2013
…Apportioning value between the drug and the diagnostic appropriately. For economists the value is jointly created and any attribution is arbitrary. However, the way that drugs and diagnostics are priced…
The Value of Diagnostic information (VODI) in Heart Failure – Recognising Value Beyond ‘Beats-Per-Minute’
3 December 2020
…Implementation should be facilitated by funding support and reimbursement of high-value diagnostics tests, including tests in primary care; and The information collected from real-world data should be shared and analysed,…